Original BioMedicals Co., Ltd. (TPEX:6483)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.00
-0.25 (-1.67%)
Apr 1, 2026, 1:59 PM CST
Market Cap981.99M +41.6%
Revenue (ttm)381.00K +786.0%
Net Income-90.30M
EPS-1.37
Shares Out66.35M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume27,535
Average Volume162,364
Open15.20
Previous Close15.00
Day's Range14.75 - 15.20
52-Week Range9.12 - 20.00
Beta0.18
RSI38.66
Earnings DateApr 2, 2026

About Original BioMedicals

Original BioMedicals Co., Ltd., engages in the development of new drugs with non-new ingredients in Taiwan. It develops OBM-A01, for the treatment of acute radiation injury, including nuclear radiation and solar radiation exposed in space; OBM-B01, a cyanide compound drug for protection against toxic gases from fires; and CCM-CL, a cyclic polypeptide antibiotic. The company was founded in 2011 and is based in Tainan City, Taiwan. [Read more]

Sector Healthcare
Founded 2011
Employees 23
Stock Exchange Taipei Exchange
Ticker Symbol 6483
Full Company Profile

Financial Performance

Financial Statements